HomeCompareBCTXW vs SPHD

BCTXW vs SPHD: Dividend Comparison 2026

BCTXW yields 222222.22% · SPHD yields 4.33%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BCTXW wins by $1.4076449094288678e+30M in total portfolio value
10 years
BCTXW
BCTXW
● Live price
222222.22%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.4076449094288678e+30M
Annual income
$1,406,399,938,745,922,600,000,000,000,000,000,000.00
Full BCTXW calculator →
SPHD
SPHD
● Live price
4.33%
Share price
$49.34
Annual div
$2.14
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$26.5K
Annual income
$571.32
Full SPHD calculator →

Portfolio growth — BCTXW vs SPHD

📍 BCTXW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBCTXWSPHD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BCTXW + SPHD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BCTXW pays
SPHD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BCTXW
Annual income on $10K today (after 15% tax)
$18,888,889.10/yr
After 10yr DRIP, annual income (after tax)
$1,195,439,947,934,034,100,000,000,000,000,000,000.00/yr
SPHD
Annual income on $10K today (after 15% tax)
$367.92/yr
After 10yr DRIP, annual income (after tax)
$485.62/yr
At 15% tax rate, BCTXW beats the other by $1,195,439,947,934,034,100,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BCTXW + SPHD for your $10,000?

BCTXW: 50%SPHD: 50%
100% SPHD50/50100% BCTXW
Portfolio after 10yr
$7.038224547144339e+29M
Annual income
$703,199,969,372,961,300,000,000,000,000,000,000.00/yr
Blended yield
99.91%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BCTXW buys
0
SPHD buys
0
No recent congressional trades found for BCTXW or SPHD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBCTXWSPHD
Forward yield222222.22%4.33%
Annual dividend / share$2.00$2.14
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$1.4076449094288678e+30M$26.5K
Annual income after 10y$1,406,399,938,745,922,600,000,000,000,000,000,000.00$571.32
Total dividends collected$1.4075633997820162e+30M$5.1K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: BCTXW vs SPHD ($10,000, DRIP)

YearBCTXW PortfolioBCTXW Income/yrSPHD PortfolioSPHD Income/yrGap
1← crossover$22,232,922$22,222,222.47$11,133$432.85+$22.22MBCTXW
2$46,198,083,549$46,174,294,322.26$12,363$450.36+$46198.07MBCTXW
3$89,718,755,932,306$89,669,323,982,908.17$13,695$467.39+$89718755.92MBCTXW
4$162,845,400,843,462,850$162,749,401,774,615,260.00$15,138$483.90+$162845400843.45MBCTXW
5$276,249,751,218,492,180,000$276,075,506,639,589,670,000.00$16,697$499.88+$276249751218492.16MBCTXW
6$437,989,491,440,595,100,000,000$437,693,904,206,791,440,000,000.00$18,382$515.31+$437989491440595136.00MBCTXW
7$649,026,193,150,457,500,000,000,000$648,557,544,394,616,000,000,000,000.00$20,198$530.17+$649026193150457544704.00MBCTXW
8$898,874,233,030,415,400,000,000,000,000$898,179,775,003,744,500,000,000,000,000.00$22,157$544.46+$8.988742330304155e+23MBCTXW
9$1,163,524,002,752,517,800,000,000,000,000,000$1,162,562,207,323,175,100,000,000,000,000,000.00$24,266$558.18+$1.1635240027525178e+27MBCTXW
10$1,407,644,909,428,867,700,000,000,000,000,000,000$1,406,399,938,745,922,600,000,000,000,000,000,000.00$26,536$571.32+$1.4076449094288678e+30MBCTXW

BCTXW vs SPHD: Complete Analysis 2026

BCTXWStock

BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies. It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor. It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers. The company has a collaboration with Incyte Corporation to evaluate combination of the Bria-IMT. BriaCell Therapeutics Corp. is based in West Vancouver, Canada.

Full BCTXW Calculator →

SPHDETF

The Invesco S&P 500 High Dividend Low Volatility ETF (Fund) is based on the S&P 500 Low Volatility High Dividend Index (Index). The Fund will invest at least 90% of its total assets in common stocks that comprise the Index. Standard & Poor's compiles, maintains and calculates the Index, which is composed of 50 securities traded on the S&P 500 Index that historically have provided high dividend yields and low volatility. The Fund and the Index are rebalanced and reconstituted semi-annually, in January and July.

Full SPHD Calculator →
📬

Get this BCTXW vs SPHD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BCTXW vs SCHDBCTXW vs JEPIBCTXW vs OBCTXW vs KOBCTXW vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.